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Abstract
An important application of modern genomics is
diagnosing genetic disorders. We use the largest publicly
available exome sequence database to show that this key
clinical service can currently be performed much more
effectively in individuals of European genetic ancestry.
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Background
It has long been argued that the concentration of large
scale genomic data generation on individuals of European
ancestry can contribute to healthcare inequalities [1, 2].
Currently, in the search for a genetic diagnosis, much of
the effort in the diagnostic sequencing paradigm is fo-
cused on candidate variants among known disease-
associated genes that are either absent or sufficiently rare
in available control reference cohorts, each of which is
considered carefully as a possible explanation for the rele-
vant presentation. Need and Goldstein specifically argued
in 2009 that our ability to effectively filter variants to iden-
tify pathogenic ones as sequencing becomes clinically rou-
tine would be very different amongst different ancestry
groups unless our knowledge of genetic variation is made
more equal across ancestry groups [1]. Unfortunately,
now with clinical sequencing becoming routine this fear
has been clearly realized. The common experience is that
when this clinical service is done today in patients of
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European ancestry, the number of candidate variants is
significantly less than in other geographic ancestry groups.
When searching for genetic aberrations responsible for
Mendelian disorders, the expectation that pathogenic
genotypes will be under strong negative selection instructs
us to focus on genotypes at low or unobserved frequencies
in the general population [3–5]. As population reference co-
horts increase in size we capture lower allele frequencies
with improved resolution [6]. The recently released Exome
Aggregation Consortium (ExAC) dataset [7, 8], which con-
tains aggregated exome sequence data from 60,252 individ-
uals with an assigned geographic ancestry, aids in identifying
allelic frequencies at an approximately sixfold lower reso-
lution than what was available from the combination of two
pre-existing datasets, the Exome Sequencing Project (ESP)
and the 1000 Genomes Project. Approximately 60.9 % of
the samples in this ExAC reference cohort are of European
ancestry, compared with 13.7 % of South Asian ancestry,
9.6 % of Latino ethnicity, 8.6 % of African (African
American) ancestry, and 7.2 % of East Asian ancestry.
Here, we evaluate the consequence of geographic ancestry
on the effectiveness of interpreting a genome among a col-
lection of 5965 individuals sequenced for various studies at
the Institute for Genomic Medicine (IGM). We use a princi-
pal component (PC) approach [9] to assign samples into
geographic ancestry groups (Additional file 1). Our cohort
comprises 5094 (85.4 %) individuals of European genetic an-
cestry, 505 (8.5 %) of primarily African ancestry, 93 (1.6 %)
of Latino ethnicity, 61 (1 %) of East Asian ancestry, and 38
(0.6 %) of South Asian ancestry; 174 (2.9 %) samples were
allocated to an “unassigned” ancestry group (Fig. 1a).
Geographic ancestry, rare variants, and
disease-associated genes
We previously described “narrative potential” [10] as the
opportunity to construct variant-disease narratives given
that every genome will contain rare variants predicted to
be damaging by in silico tools. To illustrate the value of
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ancestry matched controls, we generated rare variant distri-
butions for the different ancestry groups. The distributions
reflect the number of rare non-synonymous variants found
among the 3393 current disease-associated genes from the
Online Mendelian Inheritance in Man (OMIM) database.
The first assessment (Fig. 1b) compares the European
(blue) and non-European (red) distribution for the num-
ber of singleton non-synonymous variants each sample
has among OMIM disease-associated genes (Additional
file 1). The minor allele frequency (MAF) is based on
the internal database of 5965 IGM samples. Due to the
reduced access to ethnically matched controls, when com-
paring the distribution between the European and non-
European ancestries, we find longer candidate lists among
non-Europeans (Mann–Whitney U test p < 1 × 10−320).
After further removing variants reported in the ExAC
reference cohort (Fig. 1c) [7, 8], individuals with European
ancestry have, on average, 6.6 candidate singleton
non-synonymous variants that overlap OMIM disease-
associated genes. In comparison, we see 9.9 candidate
variants in individuals with primarily African, 10.9 in
Latino ethnicity, 12.3 in East Asian, 12.7 in South Asian,
and 8.3 in the unassigned ancestry group (Table 1). While
this illustrates that growing and diverse datasets are a crit-
ical step towards harmonizing the distribution of candi-
date variants, it is evident that the problem is not yet
solved (Fig. 1d; Mann–Whitney U test p = 5 × 10−91). As a
simple illustration, randomly selecting a European repre-
sentative finds six candidate OMIM gene variants, one
within a dominant gene. In comparison, randomly select-
ing a South Asian representative results in 13 candidate
OMIM gene variants, eight occurring in dominant genes
(Additional file 1). This is a challenge currently faced by
research, clinical, and diagnostic sequencing labs. While
the numerical difference sounds small, when you consider
that you may need to act on the basis of the patients’
genetic diagnosis, every additional candidate has a true
implication on interpretation.
Fig. 1 a Percentage representation of the 5965 IGM reference cohort across six geographic ancestry groupings. b A semi-transparent overlaid histogram
representing the tally of candidate variants between IGM’s 5094 European (Eu) individuals (blue) and the collection of non-European individuals (red)
(Mann–Whitney U test p < 1 × 10−320). The non-European distribution reflects individuals with a: Latino ethnicity (La), East Asian (EaAs), South Asian (SoAs),
primarily African (Af), and unassigned (Un) ancestry. Estimates indicate the mean number of singleton non-synonymous variants among OMIM
disease-associated genes. Singleton variants are identified based on a reference cohort of 5965 IGM sequenced samples. c Percentage representation
of the combined 66,217 IGM and ExAC reference cohorts across six geographic ancestry / ethnic groupings. d Similar to b but singleton variants were
identified based on the absence among the combined IGM and ExAC reference cohorts accumulating to 66,217 samples
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Conclusions
These analyses illustrate how unequal representation of
genetic variation can negatively affect present genomic in-
terpretation in individuals of non-European ancestry.
While the results are unsurprising given our understand-
ing of population genetics, there are still important
lessons. Firstly, these data show that it is instructive to as-
sess the allele frequencies of non-European cases in their
matched ancestry group(s). Secondly, increasing diversity
of geographic ancestry and sample size among sequenced
reference cohorts greatly ameliorates the problem (Fig. 1).
Given that sample sizes are about to explode with the
US national initiative and other large-scale international
sequencing studies, it is vital that we ensure the most
equitable distribution of the generation of genomic data
possible. Enriching our knowledge of genetic variation in
different ancestry groups remains the most effective
solution to this problem. With initiatives like the re-
cently announced Precision Medicine Initiative (PMI)
Cohort Program, this must be recognized as a high pri-
ority for the field as we move towards an era where pre-
cision medicine is a reality. If not, genomics could
further contribute to healthcare inequalities.
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Table 1 Group summaries for the number of singleton non-synonymous candidate variants in OMIM disease-associated genes
among IGM’s 5965 samples
Geographic
ancestry / ethnic group
Number of
individuals
Number of singletons using internal reference
cohort (n = 5,965)
Number of singletons using internal and ExAC reference
cohorts (n = 66,217)
Median Mean SD Median Mean SD
European 5,094 15 15.2 5.0 6 6.6 3.0
African (African American) 505 29 29.7 8.3 9 9.9 4.8
Latino ethnicity 93 28 28.3 6.0 10 10.9 5.5
East Asian 61 51 50.2 9.1 12 12.3 4.2
South Asian 38 49.5 50.5 7.4 12 12.7 3.8
Unassigned 174 24 22.7 11.9 8 8.3 5.8
Data reflect using only the internal reference cohort and then subsequently supplementing the IGM internal reference cohort with variant information from the
ExAC reference cohort of 60,252 controls of convenience
SD standard deviation
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